Pharma giant Roche is buying cancer tech startup Flatiron Health for $1.9 billion (ROG)
Saskia Uppenkamp
- Pharma giant Roche is acquiring Flatiron Health for $1.9 billion.
- The New York-based cancer technology startup had previously been valued at $1.2 billion after raising $175 million from investors including Roche.
- Flatiron collects clinical data from cancer patients — such as what medications patients have taken and how they have responded to them.
Roche is buying Flatiron Health.
The pharmaceutical giant is paying $1.9 billion for the New York-based healthcare technology startup, which collects clinical data from cancer patients — such as what medications patients have taken and how they have responded to them.See the rest of the story at Business Insider
NOW WATCH: I've used the iPhone for 10 years and these are my favorite tips and tricks
See Also:
- A photographer captured these dismal photos of life in North Korea on his phone
- What abandoned Olympic venues from around the world look like today
- The most crowdfunded watch company ever is making $1,000+ luxury watches affordable for everyone
SEE ALSO: Flatiron Health is leaving the Flatiron neighborhood behind as it amps up its cancer technology